23:17 , Jun 20, 2019 |  BC Extra  |  Company News

Spero's TB program first licensing deal for Gates Medical Research Institute

A partnership to develop Spero's Phase I compound for tuberculosis is the first licensing deal announced by Gates MRI, the translational research institute launched by the Bill & Melinda Gates Foundation in 2017. Spero Therapeutics...
00:31 , May 10, 2019 |  BC Innovations  |  Product Development

The time is now: novel partnerships and funding models for accelerating science to the marketplace

We are in a golden age of biopharmaceutical development, enabled by the convergence of technology and science. But much of the gold is left unmined because mechanisms are not deployed to develop all compounds that...